Prescription ·Strong evidence ·Reviewed May 2026
Acarbose is an oral alpha-glucosidase inhibitor used with diet and exercise to improve glycemic control in adults with type 2 diabetes by reducing post-meal glucose spikes. It acts locally in the intestine and commonly causes flatulence, diarrhea, and abdominal discomfort. If hypoglycemia occurs with insulin or sulfonylureas, oral glucose (dextrose), not sucrose, should be used for treatment.
The bottom line
Evidence rating strong. Most-documented uses: reduces postprandial glucose excursions, lowers a1c modestly in type 2 diabetes, does not cause hypoglycemia alone. 3 sources indexed (1998–2026), with 3 interaction records on file.
Core mechanism
Acarbose reversibly inhibits brush-border alpha-glucosidases, delaying breakdown of complex carbohydrates and disaccharides into absorbable monosaccharides. This slows carbohydrate absorption and reduces postprandial glucose excursions without directly increasing insulin secretion. Undigested carbohydrate reaching the colon produces fermentation-related gas and GI adverse effects.1,2
Must be taken with the first bite of a carbohydrate-containing meal to work. Separate from binding fibers if GI tolerance or absorption is a concern.
Berberine may lower glucose and add to the glucose-lowering effects of Acarbose.
Recommendation: Increase glucose monitoring when starting, stopping, or changing the supplement; coordinate diabetes medication adjustments with the prescriber.
Alpha-Lipoic Acid may lower glucose and add to the glucose-lowering effects of Acarbose.
Recommendation: Increase glucose monitoring when starting, stopping, or changing the supplement; coordinate diabetes medication adjustments with the prescriber.
Psyllium and acarbose can both blunt postprandial glucose rise and can both cause gastrointestinal bloating or gas.
Recommendation: Titrate slowly, monitor postprandial glucose, and separate dosing if GI intolerance occurs.
Numbered references. Citations throughout the page link here.
Acarbose reduced progression to diabetes in impaired glucose tolerance but caused GI effects.
Acarbose reduced digoxin exposure in a crossover study.
Label recommends dosing with first bite and oral glucose for hypoglycemia when combined with insulin or sulfonylureas.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
